Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|34|3893-3917

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.34, 2014-11, pp. : 3893-3917

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Structure-Based Design of Neuraminidase Inhibitors as Antiinfluenza Agents

By  

Current Medicinal Chemistry, Vol. 19, Iss. 34, 2012-12 ,pp. : 5885-5894

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Anti-Alzheimer Agents: Current Ligand-Based Approaches toward the Design of Acetylcholinesterase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-06 ,pp. : 583-591

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents

By  

Current Bioactive Compounds, Vol. 13, Iss. 3, 2017-07 ,pp. : 213-222

Bentham Science Publishers

Access to resources Recommend Favorite

New Opportunities in the Structure-based Design of Anti-Protozoan Agents

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 1, 2017-01 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in QSAR-based Identification and Design of Anti-Tubercular Agents

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4418-4426

Bentham Science Publishers

Access to resources Recommend Favorite